Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study

被引:1
作者
Torzsa Peter [1 ]
Devadiga Raghavendra [2 ]
Tafalla Monica [3 ]
机构
[1] Semmelweis Egyet, Altalanos Orvostudomanyi Kar, Csaladorvosi Tanszek, Budapest, Hungary
[2] GSK, CDOC B, 5 Embassy Links,SRT Rd, Bangalore 560052, Karnataka, India
[3] GSK, Ave Fleming 20, B-1300 Wavre, Belgium
关键词
seroprevalence; Bordetella pertussis; epidemiology; primary care; Hungary; VACCINATION; POPULATION; SEROEPIDEMIOLOGY; IMMUNIZATION; CIRCULATION; ADOLESCENTS; DIPHTHERIA; TETANUS; INFANTS; IMPACT;
D O I
10.1556/650.2018.30941
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Pertussis (whooping cough) is an acute respiratory tract infection caused by Bordetella pertussis that is characterized by a chronic, severe cough. The optimum immunization schedule for pertussis is unclear, so these vary by countries. Aim: To estimate the seroprevalence of pertussis in adults in Hungary. Method: Serum anti-pertussis toxin immunoglobulin G (anti-PT IgG) antibody levels were analyzed using enzyme-linked immunosorbent assay in adults in general practitioners' practices during one year. Sera were classified following manufacturer's instructions as: strongly indicative of current/recent infection (>= 1.5 optical density [OD] units); indicative of current/recent infection (>= 1.0 OD units); seropositive (>0.3 OD units); or seronegative (<= 0.3 OD units). Results: 1999 adults (60.6% female; mean age 47.4 +/- 17.7 years) were included. 14.8% were seropositive, 1.1% were indicative of current/recent infection, and 0.1% were strongly indicative of current/recent infection. Conclusions: 85.2% of the subjects were seronegative and therefore susceptible to pertussis infection. Approximately 1% was suspicious of current/recent pertussis infection, potentially transmissible to susceptible young infants. Vaccination of adults is a key way to indirectly protect infants.
引用
收藏
页码:503 / 510
页数:8
相关论文
共 45 条
  • [1] [Anonymous], 2016, SURV ATL INF DIS
  • [2] [Anonymous], 2016, REC IMM PERT ALL EU
  • [3] [Anonymous], 2015, POPULATION PYRAMIDS
  • [4] [Anonymous], 2016, REC AD IMM SCHED AD
  • [5] Seroprevalence studies of pertussis: what have we learned from different immunized populations
    Barkoff, Alex-Mikael
    Grondahl-Yli-Hannuksela, Kirsi
    He, Qiushui
    [J]. PATHOGENS AND DISEASE, 2015, 73 (07):
  • [6] A Belgian Serosurveillance/Seroprevalence Study of Diphtheria, Tetanus and Pertussis Using a Luminex xMAP Technology-Based Pentaplex
    Cabore, Raissa Nadege
    Pierard, Denis
    Huygen, Kris
    [J]. VACCINES, 2016, 4 (02)
  • [7] The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia
    Carcione, Dale
    Regan, Annette K.
    Tracey, Lauren
    Mak, Donna B.
    Gibbs, Robyn
    Dowse, Gary K.
    Bulsara, Max
    Effler, Paul V.
    [J]. VACCINE, 2015, 33 (42) : 5654 - 5661
  • [8] Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years
    Chen, Zhiyun
    Zhang, Jing
    Cao, Lina
    Zhang, Nan
    Zhu, Junping
    Ping, Guoling
    Zhao, Jianhong
    Li, Shuming
    He, Qiushui
    [J]. JOURNAL OF INFECTION, 2016, 73 (01) : 38 - 44
  • [9] Seroprevalence of Bordetella pertussis in the Mexican population: a cross-sectional study
    Conde-Glez, C.
    Lazcano-Ponce, E.
    Rojas, R.
    deAntonio, R.
    Romano-Mazzotti, L.
    Cervantes, Y.
    Ortega-Barria, E.
    [J]. EPIDEMIOLOGY AND INFECTION, 2014, 142 (04) : 706 - 713
  • [10] Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries
    Cutts, Felicity T.
    Hanson, Matt
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2016, 21 (09) : 1086 - 1098